# OnCo record idea-bio2-anamorelin-access (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-bio2-anamorelin-access/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-bio2-anamorelin-access" ;
  schema:name "Get the one approved appetite drug licensed beyond a single country"@en ;
  schema:description "A drug that improves appetite and lean weight in cancer wasting is approved in Japan but almost nowhere else. Reviewing the existing evidence could widen access quickly."@en ;
  schema:url <https://onco.cc/ideas/idea-bio2-anamorelin-access/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(10)70218-7> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/exercise-oncology/> ;
  onco:institutions <https://onco.cc/institutions/ncc-japan/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-cachexia-supportive/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-fearon-lancet-oncol/> .
